Chimeric OspA genes, proteins and methods of use thereof

Title: Chimeric OspA genes, proteins and methods of use thereof

Abstract

The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.

Inventors:: Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J.

Issue Date:: 2018-02-20

Research Org.:: Research Foundation of the State University of New York, Amherst, NY; Brookhaven National Lab. (BNL), Upton, NY (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1422826

Patent Number(s):: 9,895,434

Application Number:: 15/049,438

Assignee:: Brookhaven Science Associates, LLC (Upton, NY)

DOE Contract Number:: DE-SC0012704

Resource Type:: Patent

Resource Relation:: Patent File Date: 2016 Feb 22

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES

Citation Formats


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., and Luft, Benjamin J. Chimeric OspA genes, proteins and methods of use thereof.  United States: N. p., 2018. 
        Web.

Copy to clipboard


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., & Luft, Benjamin J. Chimeric OspA genes, proteins and methods of use thereof.  United States.

Copy to clipboard


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., and Luft, Benjamin J. Tue .  
        "Chimeric OspA genes, proteins and methods of use thereof".  United States.  https://www.osti.gov/servlets/purl/1422826.

Copy to clipboard


                    
@article{osti_1422826,

  title        = {Chimeric OspA genes, proteins and methods of use thereof},

  author       = {Crowe, Brian A. and Livey, Ian and O'Rourke, Maria and Schwendinger, Michael and Dunn, John J. and Luft, Benjamin J.},

  abstractNote = {The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {2018},

  month        = {2}

}

Copy to clipboard

Patent:

View Patent

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Non-immunogenic polypeptides
patent, December 1979

Davis, Frank F.; Van Es, Theodorus; Palczuk, Nicholas C.
US Patent Document 4,179,337
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4179337

Immunometric assays using monoclonal antibodies
patent, March 1983

David, Gary S.; Greene, Howard E.
US Patent Document 4,376,110
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4376110

Recombinant immunoglobin preparations
patent, March 1989

Cabilly, Shmuel; Heyneker, Herbert; Holmes, William
US Patent Document 4,816,567
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4816567

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
patent, August 1989

Lockhoff, Oswald; Hayauchi, Yutaka; Stadler, Peter
US Patent Document 4,855,283
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4855283

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
patent, October 1989

Berger, Frank M.; Bona, Constantin; Lechevalier, Mary P.
US Patent Document 4,877,612
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4877612

Method of making a projection viewable transparency comprising an electrostatographic toner image
patent, August 1993

Aslam, Muhammed; Light, William
US Patent Document 5,234,784
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5234784

Preparation and use of polyethylene glycol propionaldehyde
patent, October 1993

Harris, J. Milton; Sedaghat-Herati, M. R.
US Patent Document 5,252,714
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5252714

Humanized immunoglobulins
patent, December 1996

Queen, Cary L.; Selick, Harold E.
US Patent Document 5,585,089
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5585089

Borrelia antigen
patent, November 1997

Bergstrom, Sven; Barbour, Alan G.
US Patent Document 5,688,512
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5688512

Humanized immunoglobulins
patent, December 1997

Queen, Cary L.; Co, Man Sung; Schneider, William P.
US Patent Document 5,693,762
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5693762

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
patent, July 1998

Barbour, Alan George; Bergstrom, Sven; Hansson, Lennart
US Patent Document 5,777,095
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5777095

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, August 1999

Lobet, Yves; Simon, Markus; Schaible, Ulrich
US Patent Document 5,942,236
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5942236

Borrelia antigen
patent, July 2000

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,083,722
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6083722

Borrelia burdorferi Osp A and B proteins and immunogenic peptides
patent, November 2000

Barbour, Alan George; Bergstrom, Sven; Hansson, Lennart
US Patent Document 6,143,872
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6143872

OspA DNA and lyme disease vaccine
patent, February 2001

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,183,986
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6183986

Borrelia antigen
patent, March 2001

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,203,798
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6203798

Chimeric proteins comprising borrelia polypeptides and uses therefor
patent, June 2001

Dunn, John J.; Luft, Benjamin J.
US Patent Document 6,248,562
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6248562

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, January 2004

Lobet, Yves; Simon, Markus; Schaible, Ulrich
US Patent Document6,676,942
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6676942

Recombinant constructs of Borrelia burgdorferi
patent, March 2006

Dattwyler, Raymond J.; Gomes-Solecki, Maria J. C.; Luft, Benjamin J.
US Patent Document 7,008,625
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F7008625

Compositions and methods for administering Borrelia burgdorferi antigens
patent, August 2006

Barbour, Alan G.; Luke, Catherine J.
US Patent Document 7,094,391
URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F7094391

Altered ospa of borrelia burgdorferi
patent-application, December 2009

Luft, Benjamin J.; Dunn, John J.; Koide, Shohei
US Patent Document 12/313443; 20090326200
URL: http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220090326200%22.PGNR.&OS=DN/20090326200&RS=DN/20090326200

Basic local alignment search tool
journal, October 1990

Altschul, Stephen F.; Gish, Warren; Miller, Webb
Journal of Molecular Biology, Vol. 215, Issue 3, p. 403-410
DOI: 10.1016/S0022-2836(05)80360-2

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus
journal, January 1991

Batzer, Mark A.; Carlton, James E.; Deininger, Prescott L.
Nucleic Acids Research, Vol. 19, Issue 18, p. 5081-5081
DOI: 10.1093/nar/19.18.5081

[14] Protein biotinylation
book, January 1990

Bayer, Edward A.; Wilchek, Meir
Avidin-Biotin Technology, p. 138-160
DOI: 10.1016/0076-6879(90)84268-L

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi
journal, April 1989

Bergström, S.; Bundoc, V. G.; Barbour, A. G.
Molecular Microbiology, Vol. 3, Issue 4, p. 479-486
DOI: 10.1111/j.1365-2958.1989.tb00194.x

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry
journal, March 1997

Bouchon, Bernadette; Klein, Michèle; Bischoff, Rainer
Analytical Biochemistry, Vol. 246, Issue 1, p. 52-61
DOI: 10.1006/abio.1996.9982

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen
journal, March 1981

Chu, Gilbert; Sharp, Phillip A.
Gene, Vol. 13, Issue 2, p. 197-202
DOI: 10.1016/0378-1119(81)90008-1

Effects of amino acid sequence changes on antibody-antigen interactions
journal, January 1994

Colman, P. M.
Research in Immunology, Vol. 145, Issue 1, p. 33-36
DOI: 10.1016/S0923-2494(94)80039-1

A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease
journal, July 1998

Sigal, Leonard H.; Zahradnik, John M.; Lavin, Philip
New England Journal of Medicine, Vol. 339, Issue 4, p. 216-222
DOI: 10.1056/NEJM199807233390402

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
journal, January 1996

de Silva, A. M.; Telford, S. R.; Brunet, L. R.
Journal of Experimental Medicine, Vol. 183, Issue 1, p. 271-275
DOI: 10.1084/jem.183.1.271

A comprehensive set of sequence analysis programs for the VAX
journal, January 1984

Devereux, John; Haeberli, Paul; Smithies, Oliver
Nucleic Acids Research, Vol. 12, Issue 1, p. 387-395
DOI: 10.1093/nar/12.1Part1.387

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA
journal, October 2000

Ding, Wei; Huang, Xiaolin; Yang, Xiaohua
Journal of Molecular Biology, Vol. 302, Issue 5, p. 1153-1164
DOI: 10.1006/jmbi.2000.4119

Gene Synthesis[New Synthetic Methods(77)]
journal, June 1989

Engels, Joachim W.; Uhlmann, Eugen
Angewandte Chemie International Edition in English, Vol. 28, Issue 6, p. 716-734
DOI: 10.1002/anie.198907161

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents
journal, December 1996

Fix, Joseph A.
Journal of Pharmaceutical Sciences, Vol. 85, Issue 12, p. 1282-1285
DOI: 10.1021/js960158a

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
journal, August 2000

Frankel, Arthur E.; Ramage, Jason; Kiser, Melanie
Protein Engineering, Design and Selection, Vol. 13, Issue 8, p. 575-581
DOI: 10.1093/protein/13.8.575

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii
journal, October 1997

Gern, Lise; Hu, Chang Min; Voet, Pierre
Vaccine, Vol. 15, Issue 14, p. 1551-1557
DOI: 10.1016/S0264-410X(97)00066-2

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
journal, July 1984

Geysen, H. M.; Meloen, R. H.; Barteling, S. J.
Proceedings of the National Academy of Sciences, Vol. 81, Issue 13, p. 3998-4002
DOI: 10.1073/pnas.81.13.3998

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
journal, January 1995

Golde, William T.; Burkot, Thomas R.; Piesman, Joseph
Vaccine, Vol. 13, Issue 5, p. 435-441
DOI: 10.1016/0264-410X(94)00027-K

A new technique for the assay of infectivity of human adenovirus 5 DNA
journal, April 1973

Graham, F. L.; van der Eb, A. J.
Virology, Vol. 52, Issue 2, p. 456-467
DOI: 10.1016/0042-6822(73)90341-3

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
journal, July 1998

Gross, Dawn M.; Forsthuber, Thomas; Tary-Lehmann, Magdalena
Science, Vol. 281, Issue 5377, p. 703-706
DOI: 10.1126/science.281.5377.703

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes?
journal, January 1997

Guerdoux-Jamet, Pascale; Hénaut, Alain; Nitschké, Patrick
DNA Research, Vol. 4, Issue 4, p. 257-265
DOI: 10.1093/dnares/4.4.257

Amino acid substitution matrices from protein blocks.
journal, November 1992

Henikoff, S.; Henikoff, J. G.
Proceedings of the National Academy of Sciences, Vol. 89, Issue 22, p. 10915-10919
DOI: 10.1073/pnas.89.22.10915

By-passing immunisation
journal, September 1992

Hoogenboom, Hennie R.; Winter, Greg
Journal of Molecular Biology, Vol. 227, Issue 2, p. 381-388
DOI: 10.1016/0022-2836(92)90894-P

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
journal, August 1985

Houghten, R. A.
Proceedings of the National Academy of Sciences, Vol. 82, Issue 15, p. 5131-5135
DOI: 10.1073/pnas.82.15.5131

Replacing the complementarity-determining regions in a human antibody with those from a mouse
journal, May 1986

Jones, Peter T.; Dear, Paul H.; Foote, Jefferson
Nature, Vol. 321, Issue 6069, p. 522-525
DOI: 10.1038/321522a0

Applications and statistics for multiple high-scoring segments in molecular sequences.
journal, June 1993

Karlin, S.; Altschul, S. F.
Proceedings of the National Academy of Sciences, Vol. 90, Issue 12, p. 5873-5877
DOI: 10.1073/pnas.90.12.5873

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine
journal, June 1994

Keller, David; Koster, Frederick T.; Marks, Donald H.
JAMA: The Journal of the American Medical Association, Vol. 271, Issue 22, p. 1764-1768
DOI: 10.1001/jama.1994.03510460056033

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Köhler, G.; Milstein, C.
Nature, Vol. 256, Issue 5517, p. 495-497
DOI: 10.1038/256495a0

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
journal, July 2005

Koide, Shohei; Yang, Xiaohua; Huang, Xiaolin
Journal of Molecular Biology, Vol. 350, Issue 2, p. 290-299
DOI: 10.1016/j.jmb.2005.04.066

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
journal, January 2000

Lakey, D. L.; Voladri, R. K. R.; Edwards, K. M.
Infection and Immunity, Vol. 68, Issue 1, p. 233-238
DOI: 10.1128/IAI.68.1.233-238.2000

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
journal, April 1997

Li, H.; Dunn, J. J.; Luft, B. J.
Proceedings of the National Academy of Sciences, Vol. 94, Issue 8, p. 3584-3589
DOI: 10.1073/pnas.94.8.3584

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
journal, February 2002

Luft, Benjamin J.; Dunn, John J.; Lawson, Catherine L.
The Journal of Infectious Diseases, Vol. 185, Issue s1, p. S46-S51
DOI: 10.1086/338463

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons
journal, January 1989

Makoff, A. J.; Oxer, M. D.; Romanos, M. A.
Nucleic Acids Research, Vol. 17, Issue 24, p. 10191-10202
DOI: 10.1093/nar/17.24.10191

By-passing immunization: Human antibodies from V-gene libraries displayed on phage
journal, December 1991

Marks, James D.; Hoogenboom, Hennie R.; Bonnert, Timothy P.
Journal of Molecular Biology, Vol. 222, Issue 3, p. 581-597
DOI: 10.1016/0022-2836(91)90498-U

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
journal, July 1963

Merrifield, R. B.
Journal of the American Chemical Society, Vol. 85, Issue 14, p. 2149-2154
DOI: 10.1021/ja00897a025

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
journal, November 1984

Morrison, S. L.; Johnson, M. J.; Herzenberg, L. A.
Proceedings of the National Academy of Sciences, Vol. 81, Issue 21, p. 6851-6855
DOI: 10.1073/pnas.81.21.6851

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
journal, April 1993

Oliyai, Reza; Stella, Valentino J.
Annual Review of Pharmacology and Toxicology, Vol. 33, Issue 1, p. 521-544
DOI: 10.1146/annurev.pa.33.040193.002513

Genetic Analysis of Protein Stability and Function
journal, December 1989

Pakula, A. A.; Sauer, R. T.
Annual Review of Genetics, Vol. 23, Issue 1, p. 289-310
DOI: 10.1146/annurev.ge.23.120189.001445

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody
journal, June 2001

Pal, U.; Montgomery, R. R.; Lusitani, D.
The Journal of Immunology, Vol. 166, Issue 12, p. 7398-7403
DOI: 10.4049/jimmunol.166.12.7398

Improved tools for biological sequence comparison.
journal, April 1988

Pearson, W. R.; Lipman, D. J.
Proceedings of the National Academy of Sciences, Vol. 85, Issue 8, p. 2444-2448
DOI: 10.1073/pnas.85.8.2444

Reshaping human antibodies for therapy
journal, March 1988

Riechmann, Lutz; Clark, Michael; Waldmann, Herman
Nature, Vol. 332, Issue 6162, p. 323-327
DOI: 10.1038/332323a0

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information
journal, April 1994

Rossolini, Gian Maria; Cresti, Stefania; Ingianni, Angela
Molecular and Cellular Probes, Vol. 8, Issue 2, p. 91-98
DOI: 10.1006/mcpr.1994.1013

Comparison of biosequences
journal, December 1981

Smith, Temple F.; Waterman, Michael S.
Advances in Applied Mathematics, Vol. 2, Issue 4, p. 482-489
DOI: 10.1016/0196-8858(81)90046-4

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
journal, July 1998

Steere, Allen C.; Sikand, Vijay K.; Meurice, François
New England Journal of Medicine, Vol. 339, Issue 4, p. 209-215
DOI: 10.1056/NEJM199807233390401

From genes to protein structure and function: novel applications of computational approaches in the genomic era
journal, January 2000

Skolnick, Jeffrey; Fetrow, Jacquelyn S.
Trends in Biotechnology, Vol. 18, Issue 1, p. 34-39
DOI: 10.1016/S0167-7799(99)01398-0

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
journal, May 1986

Studier, F. William; Moffatt, Barbara A.
Journal of Molecular Biology, Vol. 189, Issue 1, p. 113-130
DOI: 10.1016/0022-2836(86)90385-2

Antibodies that react with predetermined sites on proteins
journal, February 1983

Sutcliffe, J.; Shinnick, T.; Green, N
Science, Vol. 219, Issue 4585, p. 660-666
DOI: 10.1126/science.6186024

Induction of CD8⁺ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
journal, April 1990

Takahashi, Hidemi; Takeshfta, Toshiyuki; Morein, Bror
Nature, Vol. 344, Issue 6269, p. 873-875
DOI: 10.1038/344873a0

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Towbin, H.; Staehelin, T.; Gordon, J.
Proceedings of the National Academy of Sciences, Vol. 76, Issue 9, p. 4350-4354
DOI: 10.1073/pnas.76.9.4350

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
journal, December 1996

Van Hoecke, C.; Comberbach, M.; De Grave, D.
Vaccine, Vol. 14, Issue 17-18, p. 1620-1626
DOI: 10.1016/S0264-410X(96)00146-6

Reshaping human antibodies: grafting an antilysozyme activity
journal, March 1988

Verhoeyen, M.; Milstein, C.; Winter, G.
Science, Vol. 239, Issue 4847, p. 1534-1536
DOI: 10.1126/science.2451287

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species
journal, August 1995

Will, G.; Jauris-Heipke, S.; Schwab, E.
Medical Microbiology and Immunology, Vol. 184, Issue 2, p. 73-80
DOI: 10.1007/BF00221390

Similar Records in DOE Patents and OSTI.GOV collections:

Divinyl ether synthase gene and protein, and uses thereof

Patent Howe, Gregg A [East Lansing, MI]; Itoh, Aya [Tsuruoka, JP]

The present invention relates to divinyl ether synthase genes, proteins, and methods of their use. The present invention encompasses both native and recombinant wild-type forms of the synthase, as well as mutants and variant forms, some of which possess altered characteristics relative to the wild-type synthase. The present invention also relates to methods of using divinyl ether synthase genes and proteins, including in their expression in transgenic organisms and in the production of divinyl ether fatty acids, and to methods of suing divinyl ether fatty acids, including in the protection of plants from pathogens.
Full Text Available
Photoreactive synthetic regulator of protein function and methods of use thereof

Patent Trauner, Dirk; Isacoff, Ehud Y; Kramer, Richard H; ...

The present disclosure provides a photoreactive synthetic regulator of protein function. The present disclosure further provides a light-regulated polypeptide that includes a subject synthetic regulator. Also provided are cells and membranes comprising a subject light-regulated polypeptide. The present disclosure further provides methods of modulating protein function, involving use of light.
Full Text Available
Advanced surface-enhanced Raman gene probe systems and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention is a series of methods and systems for using the Surface-Enhanced Raman (SER)-labeled Gene Probe for hybridization, detection and identification of SER-labeled hybridized target oligonucleotide material comprising the steps of immobilizing SER-labeled hybridized target oligonucleotide material on a support means, wherein the SER-labeled hybridized target oligonucleotide material comprise a SER label attached either to a target oligonucleotide of unknown sequence or to a gene probe of known sequence complementary to the target oligonucleotide sequence, the SER label is unique for the target oligonucleotide strands of a particular sequence wherein the SER-labeled oligonucleotide is hybridized to its complementarymore »« less
Full Text Available
Surface enhanced Raman gene probe and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention disclosed herein is a new gene probe biosensor and methods thereof based on surface enhanced Raman scattering (SERS) label detection. The SER gene probe biosensor comprises a support means, a SER gene probe having at least one oligonucleotide strand labeled with at least one SERS label, and a SERS active substrate disposed on the support means and having at least one of the SER gene probes adsorbed thereon. Biotargets such as bacterial and viral DNA, RNA and PNA are detected using a SER gene probe via hybridization to oligonucleotide strands complementary to the SER gene probe. Themore »« less
Full Text Available
Surface enhanced Raman gene probe and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention disclosed herein is a new gene probe biosensor and methods thereof based on surface enhanced Raman scattering (SERS) label detection. The SER gene probe biosensor comprises a support means, a SER gene probe having at least one oligonucleotide strand labeled with at least one SERS label, and a SERS active substrate disposed on the support means and having at least one of the SER gene probes adsorbed thereon. Biotargets such as bacterial and viral DNA, RNA and PNA are detected using a SER gene probe via hybridization to oligonucleotide strands complementary to the SER gene probe. Themore »« less
Full Text Available

Similar Records

Title: Chimeric OspA genes, proteins and methods of use thereof

Abstract

Citation Formats

Non-immunogenic polypeptides patent, December 1979

Immunometric assays using monoclonal antibodies patent, March 1983

Recombinant immunoglobin preparations patent, March 1989

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas patent, August 1989

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process patent, October 1989

Method of making a projection viewable transparency comprising an electrostatographic toner image patent, August 1993

Preparation and use of polyethylene glycol propionaldehyde patent, October 1993

Humanized immunoglobulins patent, December 1996

Borrelia antigen patent, November 1997

Humanized immunoglobulins patent, December 1997

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 patent, July 1998

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent, August 1999

Borrelia antigen patent, July 2000

Borrelia burdorferi Osp A and B proteins and immunogenic peptides patent, November 2000

OspA DNA and lyme disease vaccine patent, February 2001

Borrelia antigen patent, March 2001

Chimeric proteins comprising borrelia polypeptides and uses therefor patent, June 2001

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent, January 2004

Recombinant constructs of Borrelia burgdorferi patent, March 2006

Compositions and methods for administering Borrelia burgdorferi antigens patent, August 2006

Altered ospa of borrelia burgdorferi patent-application, December 2009

Basic local alignment search tool journal, October 1990

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus journal, January 1991

[14] Protein biotinylation book, January 1990

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi journal, April 1989

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry journal, March 1997

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen journal, March 1981

Effects of amino acid sequence changes on antibody-antigen interactions journal, January 1994

A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease journal, July 1998

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. journal, January 1996

A comprehensive set of sequence analysis programs for the VAX journal, January 1984

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA journal, October 2000

Gene Synthesis[New Synthetic Methods(77)] journal, June 1989

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents journal, December 1996

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor journal, August 2000

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii journal, October 1997

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. journal, July 1984

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi journal, January 1995

A new technique for the assay of infectivity of human adenovirus 5 DNA journal, April 1973

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis journal, July 1998

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes? journal, January 1997

Amino acid substitution matrices from protein blocks. journal, November 1992

By-passing immunisation journal, September 1992

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. journal, August 1985

Replacing the complementarity-determining regions in a human antibody with those from a mouse journal, May 1986

Applications and statistics for multiple high-scoring segments in molecular sequences. journal, June 1993

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine journal, June 1994

Continuous cultures of fused cells secreting antibody of predefined specificity journal, August 1975

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA journal, July 2005

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons journal, January 2000

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab journal, April 1997

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi journal, February 2002

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons journal, January 1989

By-passing immunization: Human antibodies from V-gene libraries displayed on phage journal, December 1991

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide journal, July 1963

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. journal, November 1984

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery journal, April 1993

Genetic Analysis of Protein Stability and Function journal, December 1989

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody journal, June 2001

Improved tools for biological sequence comparison. journal, April 1988

Reshaping human antibodies for therapy journal, March 1988

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information journal, April 1994

Comparison of biosequences journal, December 1981

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant journal, July 1998

From genes to protein structure and function: novel applications of computational approaches in the genomic era journal, January 2000

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes journal, May 1986

Antibodies that react with predetermined sites on proteins journal, February 1983

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs journal, April 1990

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. journal, September 1979

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults journal, December 1996

Reshaping human antibodies: grafting an antilysozyme activity journal, March 1988

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species journal, August 1995

Non-immunogenic polypeptides
patent, December 1979

Immunometric assays using monoclonal antibodies
patent, March 1983

Recombinant immunoglobin preparations
patent, March 1989

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
patent, August 1989

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
patent, October 1989

Method of making a projection viewable transparency comprising an electrostatographic toner image
patent, August 1993

Preparation and use of polyethylene glycol propionaldehyde
patent, October 1993

Humanized immunoglobulins
patent, December 1996

Borrelia antigen
patent, November 1997

Humanized immunoglobulins
patent, December 1997

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
patent, July 1998

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, August 1999

Borrelia antigen
patent, July 2000

Borrelia burdorferi Osp A and B proteins and immunogenic peptides
patent, November 2000

OspA DNA and lyme disease vaccine
patent, February 2001

Borrelia antigen
patent, March 2001

Chimeric proteins comprising borrelia polypeptides and uses therefor
patent, June 2001

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, January 2004

Recombinant constructs of Borrelia burgdorferi
patent, March 2006

Compositions and methods for administering Borrelia burgdorferi antigens
patent, August 2006

Altered ospa of borrelia burgdorferi
patent-application, December 2009

Basic local alignment search tool
journal, October 1990

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus
journal, January 1991

[14] Protein biotinylation
book, January 1990

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi
journal, April 1989

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry
journal, March 1997

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen
journal, March 1981

Effects of amino acid sequence changes on antibody-antigen interactions
journal, January 1994

A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease
journal, July 1998

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
journal, January 1996

A comprehensive set of sequence analysis programs for the VAX
journal, January 1984

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA
journal, October 2000

Gene Synthesis[New Synthetic Methods(77)]
journal, June 1989

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents
journal, December 1996

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
journal, August 2000

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii
journal, October 1997

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
journal, July 1984

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
journal, January 1995

A new technique for the assay of infectivity of human adenovirus 5 DNA
journal, April 1973

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
journal, July 1998

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes?
journal, January 1997

Amino acid substitution matrices from protein blocks.
journal, November 1992

By-passing immunisation
journal, September 1992

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
journal, August 1985

Replacing the complementarity-determining regions in a human antibody with those from a mouse
journal, May 1986

Applications and statistics for multiple high-scoring segments in molecular sequences.
journal, June 1993

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine
journal, June 1994

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
journal, July 2005

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
journal, January 2000

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
journal, April 1997

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
journal, February 2002

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons
journal, January 1989

By-passing immunization: Human antibodies from V-gene libraries displayed on phage
journal, December 1991

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
journal, July 1963

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
journal, November 1984

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
journal, April 1993

Genetic Analysis of Protein Stability and Function
journal, December 1989

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody
journal, June 2001

Improved tools for biological sequence comparison.
journal, April 1988

Reshaping human antibodies for therapy
journal, March 1988

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information
journal, April 1994

Comparison of biosequences
journal, December 1981

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
journal, July 1998

From genes to protein structure and function: novel applications of computational approaches in the genomic era
journal, January 2000

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
journal, May 1986

Antibodies that react with predetermined sites on proteins
journal, February 1983

Induction of CD8⁺ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
journal, April 1990

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
journal, December 1996

Reshaping human antibodies: grafting an antilysozyme activity
journal, March 1988

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species
journal, August 1995